Leaders

Dr Sam Banister
Co-Founder and CSO

Joshua Ismin
Co-Founder and President
Investment Team
challenges
Existing antidepressants take several weeks/sometimes months to be effective, and often patients need to try several different types of antidepressants to find a therapy that works for them.
solution
Xylo has developed a lead therapeutic candidate that it believes will provide a rapid and durable effect based on a known, natural effective treatment, but designed to remove unwanted side effects through clever drug design.
You might also like
For founders
Building for the systems that matter? Pitch us.
We back founders turning breakthrough science into category-defining companies.
For investors
Invest with Main Sequence
Access Australia's deep tech frontier alongside us.






